Candel Therapeutics (CADL) Stock Analysis & Winston Score

Candel Therapeutics is a small biotech company that tries to help the immune system fight cancer. It develops experimental treatments called oncolytic viral immunotherapies, which use engineered viruses to attack tumor cells and trigger an immune response. Its main customers are cancer patients enrolled in clinical trials, and it focuses on hard-to-treat cancers like prostate cancer and pancreatic cancer.

Candel does not yet sell any approved products, so it currently earns no meaningful revenue. The company is based in Lexington, Massachusetts, and funds its operations through grants, partnerships, and by raising money from investors. Its pipeline includes two main platforms — CAN-2409 and CAN-3110 — but like most early-stage biotechs, it faces significant risk: if clinical trials fail to show that its treatments are safe and effective, the company could run out of cash before reaching the market.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-160.9% YoY

YoY Growth Rate

Earnings declining

Insider Activity

13.6%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~3 years

$195M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$195M cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

-11.6%

Weak — -11.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.01

Conservative — low debt load (0.01)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial